In 2001, the Perinatal HIV Prevention Trial started in Thailand, investigate whether adding a single dose of NVP in mothers and young children, in addition to the AZT regimen would further reduce transmission without adding significant risk to mother or child.
With this discovery, the researchers have blazed a path for a new use of drugs. Their results were published in the journal Nature Chemistry.Researchers from the Perinatal HIV Transmission Trial group , an international program in cooperation with Thailand, France and the United States show that two – two – drug therapy, the risk of mother to child transmission of HIV to less than 2 percent a result a result similar to using HAART during pregnancy. In the absence of intervention, 35 percent of the children to to HIV-infected mothers become infected.. This means Becomes MedicineDutch researchers Roeland Nolte and Jeroen Cornelissen have successfully converted to a virus in a unique drug dealers.of the malarial parasite is the evil genius of in that since ancient times, it has think to us, it is a trivial problem, fooled easily resolved, she writes, prior evidence support of its assertion that efforts to control malaria have it treated as an and it is did most thriving off, to date. .